V
76
4
ZTS
54
7
SJM
31
-5
HCP
60
-2
NTAP
66
-7
OXY
40
3
WEC
58
2
BIIB
32
3
GOOGL
50
2
UA
63
6
PSX
47
-3
EIX
80
2
HPQ
53
-16
WY
64
4
MAR
66
-2
ADSK
56
-12
PRU
67
2
BWA
50
2
MS
70
-2
HP
50
4
V
76
4
ZTS
54
7
SJM
31
-5
HCP
60
-2
NTAP
66
-7
OXY
40
3
WEC
58
2
BIIB
32
3
GOOGL
50
2
UA
63
6
PSX
47
-3
EIX
80
2
HPQ
53
-16
WY
64
4
MAR
66
-2
ADSK
56
-12
PRU
67
2
BWA
50
2
MS
70
-2
HP
50
4
Financhill
Back

Global X Solar ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
47

RAYS
Global X Solar ETF

Last Price:
10.17
Seasonality Move:
-12.63%
Buy
60

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
47
Global X Solar ETF (RAYS) is a Sell

Is Global X Solar ETF a Buy, Sell or Hold?

  • The current Global X Solar ETF [RAYS] share price is $10.17. The Score for RAYS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RAYS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RAYS Stock Price Chart

What is Global X Solar ETF's stock price today?

  • The Global X Solar ETF share price today is $10.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RAYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $137.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RAYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 48.51 Sell
Chaikin Money Flow: 8955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.93 - 10.89) Sell
Bollinger Bands (100): (9.67 - 10.83) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 69.97 Buy
Chaikin Money Flow: 2429824 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.69) Buy
Bollinger Bands (100): (119.21 - 142.01) Buy

RAYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.92 Buy
20-day SMA: 10.34 Sell
50-day SMA: 10.56 Sell
200-day SMA: 10.75 Sell
8-day EMA: 10.01 Buy
20-day EMA: 10.2 Sell
50-day EMA: 10.35 Sell
200-day EMA: 11.03 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.25 Buy
20-day SMA: 117.78 Buy
50-day SMA: 122.17 Buy
200-day SMA: 130.04 Buy
8-day EMA: 121.1 Buy
20-day EMA: 119.12 Buy
50-day EMA: 122.54 Buy
200-day EMA: 126.1 Buy

Global X Solar ETF Earnings Growth & RAYS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Global X Solar ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):